Pure Global AI
Disease / condition

Systemic Lupus Erythematosus clinical trials

Free access to 443 studies10+ countriesUpdated daily79 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
443
Total trials
10+
Countries
10+
Sponsors
79
Recruiting
By phase
N/A180
Phase 291
Phase 162
Phase 351
Phase 426
By status
Completed195
Recruiting79
Not yet recruit...74
Unknown37
Terminated26
Top countries
United States of America106
China44
Egypt14
France13
Japan10
Top sponsors
GlaxoSmithKline27
Assiut University13
UCB Pharma11
AstraZeneca11
Sohag University8
Recent trials
Latest clinical trials for Systemic Lupus Erythematosus
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
Second Affiliated Hospital, Sc... · China
NCT06421701Not yet recr...
Phase
Phase 1
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Moderate to Severe Systemic Lupus Erythematosus
GlaxoSmithKline · United States of America
NCT06413511Not yet recr...
Phase
Phase 1
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
GlaxoSmithKline
NCT06411249Not yet recr...
Phase
Phase 4
The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients
Sohag University
NCT06404723Not yet recr...
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Wuhan Union Hospital, China
NCT06400537Not yet recr...
Phase
Phase 1
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
RenJi Hospital
NCT06394063Not yet recr...
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
Northwell Health · United States of America
NCT06378736Recruiting
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
Hospices Civils de Lyon · France
NCT06356740Not yet recr...
Phase
Phase 2
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus
Qiong Fu
NCT06360068Not yet recr...
Phase
Phase 2
CD19/BCMA HLA-independent TCR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Wuhan Union Hospital, China
NCT06349343Not yet recr...
Phase
Phase 1
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)
Guangdong Ruishun Biotech Co.,... · China
NCT06340490Not yet recr...
Phase
Phase 1
Belimumab in SLE Synovial Inflammation and Lymph Nodes
Academisch Medisch Centrum - U... · Netherlands
NCT06327724Recruiting
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
Luminary Therapeutics
NCT06340750Not yet recr...
Phase
Phase 1
FT819 in Moderate to Severe Active Systemic Lupus Erythematosus
Fate Therapeutics · United States of America
NCT06308978Recruiting
Phase
Phase 1
A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE)
Autolus Limited · United Kingdom
NCT06333483Recruiting
Phase
Phase 1
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology...
NCT06297408Not yet recr...
Phase
Phase 1
Fatigue in Lupus Intervention Programmes (FLIP)
University of Edinburgh · United Kingdom
NCT06308770Recruiting
(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE
Sohag University · Egypt
NCT06255743Recruiting
A Study of CNTY-101 in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)
Century Therapeutics, Inc.
NCT06255028Not yet recr...
Phase
Phase 1
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
Sohag University · Egypt
NCT06294483Enrolling by...
About this profile

Access comprehensive clinical trial information for Systemic Lupus Erythematosus through Pure Global AI's free database. This collection includes 443 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 79 trials are actively recruiting participants.

Research for Systemic Lupus Erythematosus is being conducted in United States of America, China, Egypt and 7+ other countries. Leading sponsors include GlaxoSmithKline and Assiut University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 443 clinical trials studying Systemic Lupus Erythematosus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include GlaxoSmithKline, Assiut University, UCB Pharma, among others.